CELLULAR SIGNALLING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2024-04-09 ms3000001126828781 来自广西

偏重的研究方向：生物信息学
经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审

4 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2024-03-15 ms8000002086734954 来自上海

这个期刊Under review后容易接受吗？

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2024-03-14 jeinne 来自辽宁省

投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2024-03-08 ms4000000135716353 来自上海

60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀

18 0

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-07-13 bana 来自首尔

偏重的研究方向：心血管疾病
经验分享：这个杂志是不是 submit to the journal后立即就under review了？

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-04-26 ms4000000431284905 来自重庆

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;信号通路
经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-11-04 ms7000000431018817 来自天津

审稿速度:1.0 | 投稿命中率:75.0
经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收

45 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-06-29 ms3000001479435505 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：癌症;LncRNA;机制研究
经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。

41 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-08-21 1891e859aem 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：耐药
经验分享：新鲜出炉的投稿数据分享：
6-20投稿，
6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修
8-08修回
8-21接收

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2197678, encodeId=967c219e678d4, content=偏重的研究方向：生物信息学 经验分享：泛癌+单癌细胞功能，目前with editor，不知道有没有机会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Tue Apr 09 23:59:50 CST 2024, time=2024-04-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=2128354, encodeId=f3c1212835411, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;信号通路 经验分享：这个期刊效率挺高的，3月4号投稿，29号收到小修意见，4月10号修回，4月23号接收。总体而言，投稿体验不错，效率快，审稿人和编辑也很n i c e。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd698523082, createdName=ms4000000431284905, createdTime=Wed Apr 26 01:20:31 CST 2023, time=2023-04-26, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166615, encodeId=9c21216661581, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：从投稿到接收一个月零一周效率很高了。两周返回一审意见十天修回修回后两周接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Sat Nov 04 09:45:15 CST 2023, time=2023-11-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症;LncRNA;机制研究 经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：耐药 经验分享：新鲜出炉的投稿数据分享： 6-20投稿， 6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修 8-08修回 8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省)]

2023-04-28 ms1000000465565248 来自江苏省

请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？

47 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务